Literature DB >> 24719199

Biomarkers of epileptogenesis: psychiatric comorbidities (?).

Andres M Kanner1, Andrey Mazarati, Matthias Koepp.   

Abstract

The last decade has witnessed a significant shift on our understanding of the relationship between psychiatric disorders and epilepsy. While traditionally psychiatric disorders were considered as a complication of the underlying seizure disorder, new epidemiologic data, supported by clinical and experimental research, have suggested the existence of a bidirectional relation between the two types of conditions: not only are patients with epilepsy at greater risk of experiencing a psychiatric disorder, but patients with primary psychiatric disorders are at greater risk of developing epilepsy. Do these data suggest that some of the pathogenic mechanisms operant in psychiatric comorbidities play a role in epileptogenesis? The aim of this article is to review the epidemiologic data that demonstrate that primary psychiatric disorders are more frequent in people who develop epilepsy, before the onset of the seizure disorder than among controls. The next question looks at the available data of pathogenic mechanisms of primary mood disorders and their potential for facilitating the development and/or exacerbation in the severity of epileptic seizures. Finally, we review data derived from experimental studies in animal models of depression and epilepsy that support a potential role of pathogenic mechanisms of mood disorders in the development of epileptic seizures and epileptogenesis. The data presented in this article do not yet establish conclusive evidence of a pathogenic role of psychiatric comorbidities in epileptogenesis, but raise important research questions that need to be investigated in experimental, clinical, and population-based epidemiologic research studies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24719199      PMCID: PMC3996129          DOI: 10.1007/s13311-014-0271-4

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  191 in total

Review 1.  Rodent models of depression: reexamining validity without anthropomorphic inference.

Authors:  Philip V Holmes
Journal:  Crit Rev Neurobiol       Date:  2003

Review 2.  Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms.

Authors:  G K Aghajanian; J S Sprouse; P Sheldon; K Rasmussen
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

3.  In vivo interaction between serotonin and galanin receptors types 1 and 2 in the dorsal raphe: implication for limbic seizures.

Authors:  Andrey M Mazarati; Roger A Baldwin; Steve Shinmei; Raman Sankar
Journal:  J Neurochem       Date:  2005-10-07       Impact factor: 5.372

4.  The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death.

Authors:  R M Sapolsky
Journal:  Biol Psychiatry       Date:  2000-10-15       Impact factor: 13.382

5.  Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.

Authors:  Susan E Kennedy; Robert A Koeppe; Elizabeth A Young; Jon-Kar Zubieta
Journal:  Arch Gen Psychiatry       Date:  2006-11

6.  Buprenorphine treatment of refractory depression.

Authors:  J A Bodkin; G L Zornberg; S E Lukas; J O Cole
Journal:  J Clin Psychopharmacol       Date:  1995-02       Impact factor: 3.153

7.  Neuropsychiatric morbidity in focal epilepsy.

Authors:  Sophia J Adams; Terence J O'Brien; John Lloyd; Christine J Kilpatrick; Michael R Salzberg; Dennis Velakoulis
Journal:  Br J Psychiatry       Date:  2008-06       Impact factor: 9.319

Review 8.  Cortisol and depression: three questions for psychiatry.

Authors:  J Herbert
Journal:  Psychol Med       Date:  2012-05-08       Impact factor: 7.723

9.  Depression after status epilepticus: behavioural and biochemical deficits and effects of fluoxetine.

Authors:  Andréy Mazarati; Prabha Siddarth; Roger A Baldwin; Don Shin; Rochelle Caplan; Raman Sankar
Journal:  Brain       Date:  2008-06-17       Impact factor: 13.501

10.  Different emotional disturbances in two experimental models of temporal lobe epilepsy in rats.

Authors:  Marion Inostroza; Elena Cid; Liset Menendez de la Prida; Carmen Sandi
Journal:  PLoS One       Date:  2012-06-15       Impact factor: 3.240

View more
  18 in total

Review 1.  Can Neurochemical Changes of Mood Disorders Explain the Increase Risk of Epilepsy or its Worse Seizure Control?

Authors:  Andres M Kanner
Journal:  Neurochem Res       Date:  2017-07-01       Impact factor: 3.996

2.  Inducible nitric oxide synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the rat model.

Authors:  Marson Putra; Shaunik Sharma; Meghan Gage; Grace Gasser; Andy Hinojo-Perez; Ashley Olson; Adriana Gregory-Flores; Sreekanth Puttachary; Chong Wang; Vellareddy Anantharam; Thimmasettappa Thippeswamy
Journal:  Neurobiol Dis       Date:  2019-03-30       Impact factor: 5.996

3.  Novel concepts in epileptogenesis and its prevention.

Authors:  Lara E Jehi; Annamaria Vezzani
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

4.  2014 Epilepsy Benchmarks Area IV: Limit or Prevent Adverse Consequence of Seizures and Their Treatment Across The Lifespan.

Authors:  Alica M Goldman; W Curt LaFrance; Tim Benke; Miya Asato; Dan Drane; Alison Pack; Tanvir Syed; Robert Doss; Samden Lhatoo; Brandy Fureman; Ray Dingledine
Journal:  Epilepsy Curr       Date:  2016 May-Jun       Impact factor: 7.500

5.  Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model.

Authors:  Antonio Leo; Rita Citraro; Nicola Amodio; Caterina De Sarro; Maria Eugenia Gallo Cantafio; Andrew Constanti; Giovambattista De Sarro; Emilio Russo
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 6.  The relevance of inter- and intrastrain differences in mice and rats and their implications for models of seizures and epilepsy.

Authors:  Wolfgang Löscher; Russell J Ferland; Thomas N Ferraro
Journal:  Epilepsy Behav       Date:  2017-06-23       Impact factor: 2.937

Review 7.  Epilepsy Associated Depression: An Update on Current Scenario, Suggested Mechanisms, and Opportunities.

Authors:  Tanveer Singh; Rajesh Kumar Goel
Journal:  Neurochem Res       Date:  2021-03-04       Impact factor: 3.996

8.  Lennox-lombroso lecture, 2013: psychiatric comorbidities through the life of the seizure disorder: a complex relation with a not so complex solution.

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2014 Nov-Dec       Impact factor: 7.500

Review 9.  Epileptogenesis.

Authors:  Asla Pitkänen; Katarzyna Lukasiuk; F Edward Dudek; Kevin J Staley
Journal:  Cold Spring Harb Perspect Med       Date:  2015-09-18       Impact factor: 6.915

Review 10.  [Depression and epilepsy : Two clinical pictures with common causes?].

Authors:  M Borgmann; M Holtkamp; M Adli; J Behr
Journal:  Nervenarzt       Date:  2016-07       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.